• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人血管性血友病因子的生物合成

Biosynthesis of human von Willebrand factor.

作者信息

Verweij C L

机构信息

Department of Molecular Biology, Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam.

出版信息

Haemostasis. 1988;18(4-6):224-45. doi: 10.1159/000215810.

DOI:10.1159/000215810
PMID:3069640
Abstract

Endothelium forms the inner lining of all blood vessels and, as a consequence, is in direct contact with the blood. Because of this and the synthesis and secretion of hemostatic components, the endothelium is able to modulate coagulation and fibrinolysis. An important hemostatic factor synthesized by endothelial cells is the von Willebrand factor (vWF). vWF is a large plasma glycoprotein which promotes the adhesion of platelets to the vessel wall after a vascular injury. vWF is initially synthesized as a pre-pro-polypeptide. During its transport to the outside of the cell, the single-chain polypeptides are assembled into multimers. The pro-polypeptide can be cleaved and also be secreted. Free pro-polypeptide is identified as von Willebrand antigen II, a plasma glycoprotein of unknown function. Plasma vWF consists of a heterogenous series of multimers, composed of an apparently single-type glycoprotein subunit, linked together by disulfide bonds. The hemostatic potency of vWF was shown to increase with increasing multimer size. Therefore, the multimeric assembly of vWF is a crucial aspect in vWF biosynthesis. Furthermore, vWF synthesized by endothelial cells can either be secreted constitutively or stored and released upon stimulation of the endothelial cell. In this review, data are presented which contribute to the understanding of the biosynthetic pathway and complex processing which vWF has to undergo before it is secreted by the endothelial cell. These data have allowed a prediction of the sequential events underlying vWF biosynthesis, processing, multimer assembly, and secretion.

摘要

内皮细胞构成所有血管的内层,因此与血液直接接触。鉴于此以及其对止血成分的合成与分泌,内皮细胞能够调节凝血和纤维蛋白溶解过程。内皮细胞合成的一种重要止血因子是血管性血友病因子(vWF)。vWF是一种大型血浆糖蛋白,在血管损伤后可促进血小板黏附于血管壁。vWF最初作为前原多肽进行合成。在其转运至细胞外的过程中,单链多肽组装成多聚体。前多肽可被切割并分泌。游离的前多肽被鉴定为血管性血友病抗原II,这是一种功能未知的血浆糖蛋白。血浆vWF由一系列异源多聚体组成,这些多聚体由一种明显单一类型的糖蛋白亚基构成,通过二硫键连接在一起。研究表明,vWF的止血效力随多聚体大小增加而增强。因此,vWF的多聚体组装是其生物合成中的一个关键环节。此外,内皮细胞合成的vWF既可以组成型方式分泌,也可以在内皮细胞受到刺激时储存并释放。在这篇综述中,呈现了有助于理解vWF在由内皮细胞分泌之前必须经历的生物合成途径和复杂加工过程的数据。这些数据使得人们能够预测vWF生物合成、加工、多聚体组装和分泌过程中相继发生的事件。

相似文献

1
Biosynthesis of human von Willebrand factor.人血管性血友病因子的生物合成
Haemostasis. 1988;18(4-6):224-45. doi: 10.1159/000215810.
2
von Willebrand factor and the endothelium.血管性血友病因子与内皮细胞
Mayo Clin Proc. 1991 Jun;66(6):621-7. doi: 10.1016/s0025-6196(12)60522-9.
3
Von Willebrand factor processing.血管性血友病因子加工
Hamostaseologie. 2017 Jan 31;37(1):59-72. doi: 10.5482/HAMO-16-06-0018. Epub 2016 Nov 21.
4
An explanation for minor multimer species in endothelial cell-synthesized von Willebrand factor.内皮细胞合成的血管性血友病因子中微小多聚体种类的解释。
J Clin Invest. 1986 Jun;77(6):2048-51. doi: 10.1172/JCI112535.
5
Thrombospondin-1 in von Willebrand factor function.血小板反应蛋白-1在血管性血友病因子功能中的作用。
Curr Drug Targets. 2008 Oct;9(10):822-32. doi: 10.2174/138945008785909329.
6
Inducible secretion of large, biologically potent von Willebrand factor multimers.大的、具有生物活性的血管性血友病因子多聚体的诱导性分泌。
Cell. 1986 Jul 18;46(2):185-90. doi: 10.1016/0092-8674(86)90735-x.
7
Control of von Willebrand factor multimer size by thrombospondin-1.血小板反应蛋白-1对血管性血友病因子多聚体大小的调控
J Exp Med. 2001 Jun 18;193(12):1341-9. doi: 10.1084/jem.193.12.1341.
8
Endothelial cell synthesis of von Willebrand antigen II, von Willebrand factor, and von Willebrand factor/von Willebrand antigen II complex.血管性血友病因子抗原II、血管性血友病因子以及血管性血友病因子/血管性血友病因子抗原II复合物的内皮细胞合成
J Clin Invest. 1985 Apr;75(4):1089-95. doi: 10.1172/JCI111802.
9
[Biology of von Willebrand factor].[血管性血友病因子的生物学]
Nephrol Ther. 2006 Jan;2 Suppl 2:S143-8.
10
Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor.血管性血友病因子的多聚化需要高尔基体中的初始糖基化和酸性pH值。
J Cell Biol. 1986 Apr;102(4):1320-4. doi: 10.1083/jcb.102.4.1320.

引用本文的文献

1
Arginine Methylation by PRMT1 Affects ADAMTS13 Secretion and Enzymatic Activity.PRMT1介导的精氨酸甲基化影响ADAMTS13的分泌及酶活性。
Arterioscler Thromb Vasc Biol. 2025 Apr;45(4):506-522. doi: 10.1161/ATVBAHA.124.322249. Epub 2025 Feb 13.
2
Haemostatic parameters, platelet activation markers, and platelet indices among regular plateletpheresis donors.定期血小板单采捐献者的止血参数、血小板活化标志物和血小板指数
J Taibah Univ Med Sci. 2017 Dec 1;13(2):180-187. doi: 10.1016/j.jtumed.2017.10.006. eCollection 2018 Apr.
3
Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9.
利用腺病毒递送 CRISPR/Cas9 靶向体内敲入人α-1-抗胰蛋白酶 cDNA。
Gene Ther. 2018 Apr;25(2):139-156. doi: 10.1038/s41434-018-0003-1. Epub 2018 Mar 27.
4
The genetic and molecular bases of monogenic disorders affecting proteolytic systems.影响蛋白水解系统的单基因疾病的遗传和分子基础。
J Med Genet. 2005 Jul;42(7):529-39. doi: 10.1136/jmg.2004.028118.
5
Production of recombinant proteins in Chinese hamster ovary cells overexpressing the subtilisin-like proprotein converting enzyme furin.在中国仓鼠卵巢细胞中过表达枯草杆菌蛋白酶样前体蛋白转化酶弗林蛋白酶来生产重组蛋白。
Mol Biol Rep. 1996;23(2):87-95. doi: 10.1007/BF00424434.
6
Heterogeneous distribution of Weibel-Palade bodies and von Willebrand factor along the porcine vascular tree.猪血管树中魏尔-帕拉德小体和血管性血友病因子的异质性分布。
Am J Pathol. 1991 Dec;139(6):1471-84.